Clinical Trial Update: Sorafenib in Elderly mRCC

View source ↗

Summary

Completed clinical trial update on sorafenib in elderly patients with metastatic renal cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma
• Renal Cell Carcinoma Metastatic

Drugs mentioned

• Nexavar (Sorafenib)

Snippet

Sponsor: Bayer | Conditions: Carcinoma, Renal Cell | Status: COMPLETED